IL152781A0 - Melanocortin receptor ligands - Google Patents

Melanocortin receptor ligands

Info

Publication number
IL152781A0
IL152781A0 IL15278101A IL15278101A IL152781A0 IL 152781 A0 IL152781 A0 IL 152781A0 IL 15278101 A IL15278101 A IL 15278101A IL 15278101 A IL15278101 A IL 15278101A IL 152781 A0 IL152781 A0 IL 152781A0
Authority
IL
Israel
Prior art keywords
receptor ligands
melanocortin receptor
melanocortin
ligands
receptor
Prior art date
Application number
IL15278101A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL152781A0 publication Critical patent/IL152781A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
IL15278101A 2000-06-28 2001-05-31 Melanocortin receptor ligands IL152781A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21461600P 2000-06-28 2000-06-28
PCT/IB2001/000995 WO2002000654A1 (en) 2000-06-28 2001-05-31 Melanocortin receptor ligands

Publications (1)

Publication Number Publication Date
IL152781A0 true IL152781A0 (en) 2003-06-24

Family

ID=22799775

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15278101A IL152781A0 (en) 2000-06-28 2001-05-31 Melanocortin receptor ligands

Country Status (26)

Country Link
US (1) US20020072604A1 (xx)
EP (1) EP1294719A1 (xx)
JP (1) JP2004501917A (xx)
KR (1) KR20030017571A (xx)
CN (1) CN1440406A (xx)
AP (1) AP2001002196A0 (xx)
AR (1) AR030301A1 (xx)
AU (1) AU2001260548A1 (xx)
BG (1) BG107268A (xx)
BR (1) BR0111567A (xx)
CA (1) CA2412563A1 (xx)
EA (1) EA200201119A1 (xx)
EC (1) ECSP024404A (xx)
IL (1) IL152781A0 (xx)
IS (1) IS6617A (xx)
MA (1) MA26920A1 (xx)
MX (1) MXPA03000063A (xx)
NO (1) NO20026280D0 (xx)
OA (1) OA12296A (xx)
PA (1) PA8521501A1 (xx)
PE (1) PE20020208A1 (xx)
PL (1) PL360855A1 (xx)
TN (1) TNSN01097A1 (xx)
UY (1) UY26804A1 (xx)
WO (1) WO2002000654A1 (xx)
ZA (1) ZA200210277B (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001264977B2 (en) * 2000-05-30 2005-04-14 Merck & Co., Inc. Melanocortin receptor agonists
HUP0303484A2 (hu) 2001-03-02 2004-01-28 Bristol-Myers Squibb Company Melanokortin receptor modulátoraiként hasznos vegyületek és a vegyületeket tartalmazó gyógyszerkészítmények
US6911447B2 (en) 2001-04-25 2005-06-28 The Procter & Gamble Company Melanocortin receptor ligands
US7354923B2 (en) * 2001-08-10 2008-04-08 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
US7655658B2 (en) * 2001-08-10 2010-02-02 Palatin Technologies, Inc. Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
US7718802B2 (en) 2001-08-10 2010-05-18 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
CA2462200A1 (en) 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7732451B2 (en) * 2001-08-10 2010-06-08 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule
US7456184B2 (en) * 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
WO2003045313A2 (en) 2001-11-27 2003-06-05 Merck & Co. Inc. 2-aminoquinoline compounds
US7026335B2 (en) 2002-04-30 2006-04-11 The Procter & Gamble Co. Melanocortin receptor ligands
US7132539B2 (en) 2002-10-23 2006-11-07 The Procter & Gamble Company Melanocortin receptor ligands
WO2004069798A1 (ja) 2003-02-10 2004-08-19 Banyu Pharmaceutical Co.,Ltd. ピペリジン誘導体を有効成分とするメラニン凝集ホルモン受容体拮抗剤
US7727990B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine and keto-piperazine compounds
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
US7968548B2 (en) 2003-05-01 2011-06-28 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine compounds with diamine groups
WO2005021555A1 (ja) * 2003-08-29 2005-03-10 Takeda Pharmaceutical Company Limited 二環性ピペラジン化合物およびその用途
JP2005306839A (ja) * 2003-08-29 2005-11-04 Takeda Chem Ind Ltd 二環性ピペラジン化合物およびその用途
DE602005026380D1 (de) * 2004-04-08 2011-03-31 Astellas Pharma Inc Verbindung ws727713
US7709484B1 (en) 2004-04-19 2010-05-04 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
HUE037147T2 (hu) * 2005-07-08 2018-08-28 Ipsen Pharma Melanokortin-receptor ligandumai
JP2009503020A (ja) 2005-08-03 2009-01-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 肥満症の治療におけるフリバンセリンの使用
JP2009513604A (ja) 2005-10-29 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体
PE20080145A1 (es) 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
DE602007004615D1 (de) 2006-06-30 2010-03-18 Boehringer Ingelheim Pharma Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
WO2008007664A1 (fr) 2006-07-11 2008-01-17 Takeda Pharmaceutical Company Limited Composé hétérocyclique bicycique et son utilisation
US7834017B2 (en) 2006-08-11 2010-11-16 Palatin Technologies, Inc. Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
KR20090042967A (ko) 2006-08-14 2009-05-04 베링거 인겔하임 인터내셔날 게엠베하 플리반세린 제형 및 이의 제조방법
AU2007287639A1 (en) 2006-08-25 2008-02-28 Boehringer Ingelheim International Gmbh Controlled release system and method for manufacturing the same
US8563000B2 (en) 2007-05-25 2013-10-22 Ipsen Pharma S.A.S. Melanocortin receptor ligands modified with hydantoin
PE20091188A1 (es) 2007-09-12 2009-08-31 Boehringer Ingelheim Int Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen
WO2009078999A1 (en) 2007-12-17 2009-06-25 Janssen Pharmaceutica N.V. Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1076649A4 (en) * 1998-04-28 2010-06-02 Trega Biosciences Inc ISOQUINOLINE-BASED COMPOUNDS IN PLACE OF MELANOCORTIN RECEPTOR LIGANDS AND METHODS OF USE
CA2334551A1 (en) * 1998-06-11 1999-12-16 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
CA2377369A1 (en) * 1999-06-04 2000-12-14 Merck & Co., Inc. Substituted piperidines as melanocortin-4 receptor agonists

Also Published As

Publication number Publication date
US20020072604A1 (en) 2002-06-13
OA12296A (en) 2006-05-12
MA26920A1 (fr) 2004-12-20
AR030301A1 (es) 2003-08-20
TNSN01097A1 (fr) 2005-11-10
BR0111567A (pt) 2003-05-06
UY26804A1 (es) 2002-01-31
PA8521501A1 (es) 2002-10-24
KR20030017571A (ko) 2003-03-03
CN1440406A (zh) 2003-09-03
CA2412563A1 (en) 2002-01-03
IS6617A (is) 2002-11-14
AU2001260548A1 (en) 2002-01-08
NO20026280L (no) 2002-12-30
NO20026280D0 (no) 2002-12-30
MXPA03000063A (es) 2003-09-25
EP1294719A1 (en) 2003-03-26
EA200201119A1 (ru) 2003-06-26
AP2001002196A0 (en) 2002-12-21
PL360855A1 (en) 2004-09-20
BG107268A (en) 2003-06-30
ECSP024404A (es) 2003-02-06
PE20020208A1 (es) 2002-03-13
ZA200210277B (en) 2003-12-19
JP2004501917A (ja) 2004-01-22
WO2002000654A1 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
AU9631301A (en) Melanocortin receptor ligands
IL152781A0 (en) Melanocortin receptor ligands
IL157969A0 (en) Melanocortin receptor ligands
HK1044954A1 (en) Melanocortin receptor ligands
AU8066701A (en) Capsaicin receptor ligands
GB9808229D0 (en) Melanocortin receptor ligands
AU6497701A (en) Melanocortin receptor agonists
PL376702A1 (pl) Ligandy receptorów melanokortyny
IL164766A0 (en) Melanocortin receptor ligands
GB0302803D0 (en) Not available
GB0012054D0 (en) Ligands
GB0000474D0 (en) Receptor
AU1252102A (en) Receptor
GB0012121D0 (en) Bracket
HK1039547A1 (en) Heat-transpiration mat.
GB0009269D0 (en) Receptor
GB0031096D0 (en) Receptor
GB0014761D0 (en) Receptor
GB0010385D0 (en) Bracket
GB0025008D0 (en) Bracket
PL111717U1 (en) Bracket
AU142079S (en) Retaining bracket
GB0018923D0 (en) Anti-oligomer mat
GB0022798D0 (en) Mat
GB0017805D0 (en) Box-guard union bracket